Few topics sit at the intersection of two UPSC papers as neatly as gene editing does. It tests your understanding of cutting-edge biotechnology for GS-III and, at the same time, forces you to think about moral responsibility, consent, and equity for GS-IV. I have seen aspirants treat these as separate silos, and that is a mistake. Let me walk you through both dimensions together.
Where This Topic Sits in the UPSC Syllabus
Gene editing and CRISPR appear across multiple papers. The science portion falls under GS-III, while the ethical dimension is directly relevant to GS-IV. For Prelims, factual questions about CRISPR mechanism and regulation are common. Here is a clear mapping.
| Exam Stage | Paper | Syllabus Section |
|---|---|---|
| Prelims | General Studies | Science and Technology — developments and their applications |
| Mains | GS-III | Awareness in the fields of IT, Space, Computers, Robotics, Biotech |
| Mains | GS-IV | Ethics and Human Interface — ethical concerns in science, technology |
| Mains | Essay | Science-ethics crossover themes |
This topic has appeared directly or indirectly in Prelims at least 3-4 times since 2017. In Mains, questions on bioethics and technology regulation are becoming more frequent. Related topics include GMOs, stem cell research, surrogacy ethics, and data privacy.
Understanding CRISPR — The Science Made Simple
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. Think of it as a molecular pair of scissors. Scientists can use it to cut a specific part of DNA and either remove a faulty gene or insert a corrected one. The tool that does the actual cutting is a protein called Cas9.
Before CRISPR, gene editing existed but was expensive, slow, and imprecise. CRISPR changed everything because it is cheap, fast, and remarkably accurate. Jennifer Doudna and Emmanuelle Charpentier received the Nobel Prize in Chemistry in 2020 for developing this technology.
In practical terms, CRISPR can potentially cure genetic diseases like sickle cell anaemia, thalassemia, and certain cancers. In agriculture, it can create disease-resistant crops without introducing foreign DNA — which makes it different from traditional GMOs. India’s Department of Biotechnology has been exploring CRISPR applications in rice, banana, and wheat varieties.
The He Jiankui Controversy — Where Science Crossed a Line
In 2018, Chinese scientist He Jiankui announced that he had edited the genes of twin babies to make them resistant to HIV. The global scientific community condemned this act almost unanimously. He was later sentenced to prison in China.
Why was this so controversial? The editing was done on germline cells — meaning the changes would pass to future generations. No one obtained proper informed consent from the parents in a meaningful way. The long-term effects on the children remain unknown. This case became the defining example of what happens when scientific capability runs ahead of ethical frameworks.
For your GS-IV answer, this case is gold. It covers multiple ethical dimensions — consent, accountability, precautionary principle, and the limits of scientific freedom.
Ethical Dimensions for GS-IV — A Framework You Can Use
When I teach ethics to my students, I tell them to build a framework rather than memorise individual cases. Here are the key ethical concerns gene editing raises, organised for exam use.
Informed Consent: Gene editing on embryos affects a future person who cannot consent. This is fundamentally different from a patient choosing surgery. The edited individual never had a say in the modification of their own genetic code.
Equity and Access: CRISPR therapies are expensive. If gene editing becomes a way to “enhance” humans — making them smarter, taller, or stronger — only the wealthy will afford it. This creates a biological class divide. In a country like India, where healthcare access is already unequal, this concern is deeply relevant.
Designer Babies: The line between curing disease and enhancing traits is blurry. Fixing a gene that causes muscular dystrophy is therapeutic. But what about editing genes for eye colour or intelligence? The slippery slope argument is powerful here — once you permit therapeutic editing, preventing cosmetic editing becomes very difficult.
Ecological Risks: Gene drives — a CRISPR application that can spread a genetic modification through an entire wild population — could eliminate malaria-carrying mosquitoes. But wiping out a species has unpredictable consequences for ecosystems. The precautionary principle demands caution.
Playing God: Many religious and philosophical traditions raise objections to humans altering the fundamental code of life. While this is not a scientific argument, it reflects genuine public sentiment that policymakers must consider.
India’s Regulatory Framework
India does not have a standalone law on gene editing. However, several bodies and guidelines govern this space. The Genetic Engineering Appraisal Committee (GEAC) under the Ministry of Environment regulates GMOs and genetically modified organisms. The Indian Council of Medical Research (ICMR) has issued National Ethical Guidelines for Biomedical and Health Research, updated in 2017, which cover gene therapy research.
The DNA Technology (Use and Application) Regulation Bill has been discussed for years but remains contentious due to privacy concerns. India currently does not permit germline editing in humans. However, somatic cell gene therapy — editing genes in non-reproductive cells — is allowed under strict oversight.
For your exam, remember this distinction: somatic editing affects only the individual patient, while germline editing affects all future descendants. Most countries, including India, draw the ethical line between these two.
How to Use This Topic in Mains Answers
This is one of those rare topics that can appear in GS-III (biotechnology and its applications), GS-IV (ethical dilemmas in science), and even the Essay paper. I recommend preparing a single integrated set of notes that covers both dimensions.
When writing a GS-IV answer on this topic, use the stakeholder analysis method. Identify all affected parties — the patient, future generations, scientists, regulatory bodies, society at large. Then evaluate the ethical position of each stakeholder. This approach impresses examiners because it shows structured thinking rather than emotional reactions.
For GS-III, focus on applications (disease treatment, agriculture, gene drives), India-specific developments, and regulatory mechanisms. Mention GEAC, ICMR guidelines, and the Cartagena Protocol on Biosafety that India has signed.
Previous Year UPSC Questions on This Topic
Q1. What is Cas9 protein that is often mentioned in news?
(UPSC Prelims 2019 — General Studies)
Answer: Cas9 is a protein associated with the CRISPR gene-editing system. It acts as molecular scissors that can cut DNA at a specific location guided by a synthetic RNA sequence. This allows scientists to delete, modify, or insert genes with precision. The question tested whether aspirants followed developments in biotechnology beyond textbook-level knowledge.
Q2. Discuss the ethical issues involved in genetic engineering with reference to recent developments in biotechnology.
(UPSC Mains pattern — GS-IV)
Answer: Genetic engineering raises several ethical concerns. First, germline editing affects future generations who cannot provide consent — violating the principle of autonomy. Second, unequal access to gene therapies can widen social inequality, especially in developing nations. Third, the possibility of designer babies blurs the line between therapy and enhancement. The He Jiankui case of 2018 demonstrated what happens without ethical oversight — germline-edited babies were born without adequate safety testing or genuine consent. India’s ICMR guidelines prohibit germline editing, reflecting a precautionary approach. A balanced framework must protect scientific freedom while ensuring accountability, transparency, and equity. International cooperation through bodies like the WHO is essential to prevent regulatory arbitrage where scientists move to countries with weaker rules.
Q3. Examine the role of the Genetic Engineering Appraisal Committee (GEAC) in regulating GMOs in India. How effective has it been?
(UPSC Mains pattern — GS-III)
Answer: GEAC functions under the Ministry of Environment, Forest and Climate Change. It is the apex body for approving the release of genetically modified organisms in India. GEAC evaluates proposals for environmental and health safety before granting approval. However, its effectiveness has been questioned. The Bt Brinjal moratorium since 2010 shows how political considerations override scientific recommendations. Illegal cultivation of herbicide-tolerant cotton in parts of India suggests weak enforcement. Critics also point out that GEAC lacks an independent scientific advisory mechanism and sufficient transparency in its decision-making. Strengthening GEAC with statutory backing, independent experts, and public consultation mechanisms would improve India’s biotech governance.
Key Points to Remember for UPSC
- CRISPR-Cas9 is a gene-editing tool that works like molecular scissors — cheap, fast, and precise compared to older methods.
- The distinction between somatic editing (affects only the patient) and germline editing (affects future generations) is the central ethical dividing line.
- The He Jiankui case (2018, China) is the most important real-world example for ethics answers on gene editing.
- India’s regulation involves GEAC for GMOs and ICMR guidelines for human gene therapy research. No standalone gene-editing law exists yet.
- Key ethical concerns: informed consent of future generations, equity of access, designer baby risks, ecological impact of gene drives, and the precautionary principle.
- Use stakeholder analysis in GS-IV answers — identify patients, future generations, scientists, regulators, and society as distinct stakeholders.
- India is a signatory to the Cartagena Protocol on Biosafety, which governs transboundary movement of living modified organisms.
Gene editing is one of those topics where preparing well gives you material for at least three papers. Build one consolidated set of notes covering the science, the Indian regulatory landscape, and the ethical framework. Practice writing one GS-III and one GS-IV answer on this topic before your Mains. The effort will be worth it — this intersection of science and ethics is exactly what UPSC loves to test.